Patrick Kennedy is a Consultant Hepatologist at Barts Health NHS Trust and Professor of Hepatology at Barts and The London School of Medicine & Dentistry, QMUL. He has produced novel immunological work redefining disease phase in CHB; the basis for broadening treatment candidacy in HBeAg positive chronic infection. Professor Kennedy is the current Chair of the British Viral Hepatitis Group (BVHG) and former lead for the British Association for the Study of the Liver (BASL) special interest group in HBV. He was a member of the WHO guideline development group and the EASL CHB clinical practice guidelines. He provides expert opinion for the United Kingdom Advisory Panel on blood-borne viruses, in addition he is a key opinion leader in viral liver disease and a member of expert advisory panels for early drug development.

A/Professor Behzad Hajarizadeh is a clinical epidemiologist and an NHMRC Emerging Leadership Fellow in the Kirby Institute (UNSW). His main areas of research include epidemiology and clinical management of viral hepatitis, particularly in prison, and among people who inject drugs culturally and linguistically diverse communities.

A/Prof Thomas Tu leads the Hepatitis B research group at the Westmead Institute for Medical Research and is a world leader Hepatitis B virology. Drawing on lived experience of hepatitis B, he is committed to translational research that improves outcomes for affected communities.

Marrianne Black is a registered nurse who has worked extensively in the field of Gastroenterological nursing in the Tertiary acute and outpatient care and is a experienced FibroScan operator. Marrianne has worked for over 8 years at the Ethnic Communities Council of Queensland (ECCQ), as the Community Management and Treatment Coordinator for Viral Hepatitis, in the Love Health Program. This role involves working closely with bi-lingual community health workers supporting CALD communities, providing Fibroscan to, and assisting patients and GPs in the management and treatment of viral hepatitis, and as a liaison between Primary Care and Tertiary/Specialist health providers. Marrianne is also a member of the ASHM Nurse Advisory Group and the Australasian Hepatitis Association.

Prof Jane Davies MBBS MRCP(UK) DTM&H FRACP PhD Co-Director Infectious Diseases Royal Darwin Hospital Principal Research Fellow Menzies School of Health Research Prof Jane Davies is a Senior Principal Research Fellow at the Menzies School of Health Research and Co-Director of Infectious Diseases at Royal Darwin Hospital. Her research focuses on Hepatitis B spanning molecular and clinical epidemiology as well as implementation of holistic and sustainable clinical care.

Adam is a Hepatology Nurse Practitioner working at Royal Perth Hospital and within the community. With a focus on building capacity within primary care, he is passionate about reimagining approaches to viral hepatitis management and models of care, particularly for marginalised communities facing ongoing stigma and health inequity.

Patrick Kennedy is a Consultant Hepatologist at Barts Health NHS Trust and Professor of Hepatology at Barts and The London School of Medicine & Dentistry, QMUL. He has produced novel immunological work redefining disease phase in CHB; the basis for broadening treatment candidacy in HBeAg positive chronic infection. Professor Kennedy is the current Chair of the British Viral Hepatitis Group (BVHG) and former lead for the British Association for the Study of the Liver (BASL) special interest group in HBV. He was a member of the WHO guideline development group and the EASL CHB clinical practice guidelines. He provides expert opinion for the United Kingdom Advisory Panel on blood-borne viruses, in addition he is a key opinion leader in viral liver disease and a member of expert advisory panels for early drug development.

Dr Littlejohn is currently leading a project to develop a new RNA-based therapy for chronic hepatitis B, using CRISPR technology. She is an expert in HBV molecular virology and the role of HBV genotypes in pathogenesis and treatment response. She is also involved in a long term collaboration examining the molecular epidemiology of HBV in Indigenous Australian populations.

Prof. Alexander J. Thompson, MBBS/PhD/FRACP, is Professor-Director of Gastroenterology at St Vincent’s Hospital Melbourne and the University of Melbourne, Australia. He is also Honorary Adjunct Assistant Professor of Gastroenterology at Duke University Medical Center (USA). Prof. Thompson currently serves as President and Board Member of the Gastroenterological Society of Australia (GESA) and previously served on the Executive Council of the Asian Pacific Association for the Study of the Liver (APASL). He is internationally recognized for his contributions to viral hepatitis research, liver disease management, and HCC prevention.